VISCHER has advised Nuclidium AG. Walder Wyss has advised Angelini Ventures, Kurma Partners, and Wellington Partners as co-lead investors; Dentons has acted for Neva. Nuclidium AG,...
Nuclidium AG Secures CHF 79 Million in Series B Financing Round
KARL STORZ’s Acquisition Of Anklin
Walder Wyss advised the Anklin family on the deal. The Swiss company Anklin, based in Reinach, is now part of the KARL STORZ direct sales network,...
KLAR Partners Limited’s Acquisition Of BÜHLMANN Laboratories AG
Walder Wyss advised KLAR Partners on the transaction. KLAR Partners Limited acquired all shares in BÜHLMANN Laboratories AG. BÜHLMANN Laboratories is a Swiss company, located in...
Grünenthal Pharma AG’s Win Public Law Litigation in Swiss Federal Supreme Court
alder Wyss successfully represented Grünenthal Pharma AG before the Swiss Federal Supreme Court. Both the order by the Federal Office of Public Health regarding the price...